');

Aneuploidy Screening from 11 to 14 Weeks

 1: Introduction to First-Trimester Aneuploidy Screening
 2: In-Depth Look at Key Markers
 3. FMF Certification & Practical Application
 4: Key Takeaways & Everyday Practice Tips  
 5.Advanced First-Trimester Screening – Practical Cases and Learning                  Opportunities

Wed Sep 10, 2025

Aneuploidy Screening from 11 to 14 Weeks

SECTION 1. Introduction to First-Trimester Aneuploidy Screening.
What is first -trimester Aneuploidy screening?

  • This is a non-invasive method to evaluate the likelihood of chromosomal issues                  ( aneuploidies) in a developing fetus.
  • It aids in identifying disorders such as Down Syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13).
  • This screening combines ultrasound indicator, maternal blood analyze , and risk algorithms to gauge risk levels.

    Remember, Screening Does Not Equal Diagnosis! 
  • Avoid telling parents, "Your baby has Down Syndrome," based solely on nuchal translucency (NT) results!
  • Screening merely classifies the fetus as low-risk ,intermediate-risk, or high risk .
  • A high-risk  finding necessitates additional testing (like NIPT , Aminocentesis, or CVS).

What’s Included in the Screening Toolkit? 

ULTRASOUND MARKER

WHY IS IT IMPORTANT?

WHAT IS INDICATES WHEN ABNORMAL?

NUCHAL TRANSLUCENCY (NT)

Fluid at the back of the fetal neck

Trisomy 21, CHD, Turner Syndrome

Nasal Bone (NB)

Presence or absence of nasal bone

Absent NBàTrisomy 21, 18

Ductus Venosus (DV)Doppler

Blood flow in the fetal venous system

Reversed A-waveàTrisomy 21, CHD

Tricuspid Regurgitation (TR)Intra

Assesses right heart function

TR> 60 cm/sà Trisomy 21, CHD

Intracranial Translucency (IT)

Fourth ventrical fluid space

Obliteration  Open Spina Bifida

Picture it like a detective story ♂ We gather clues from these markers to unveil any potential abnormalities (aneuploidy).
SECTION 2: In-Depth Look at Key Markers
Nuchal Translucency (NT): The Star Player in Screening
  • NT is the fluid-filled area behind the fetal neck viewed in mid-sagittal  orientation.
Normal Range:
  1. Below the 95th percentile for CRL indicates low risk.
  2. Above the 95th percentile calls for further exploration!
  • A significantly elevated NT (>3.5mm) may suggest:
  1. - Trisomy 21 (most common)
  2. - Trisomy 18 & 13
  3. - Congenital Heart Disease (CHD)
  4. - Turner Syndrome (with Cystic Hygroma)
  5. - Non-genetic issues (such as fetal infections or skeletal dysplasia)
How to Properly Measure NT?
✅ Use a mid-sagittal plane.
✅ Ensure the fetal head is in a neutral position (not flexed or overly extended).
✅ Place calipers on the inner edges of the white lines (On-on method).
🚨 Frequent Errors:
❌ Measuring from an oblique angle.
❌ Including the amniotic membrane in measurements
Nasal Bone (NB): The "Nose" Knows! 👃
The absence of a nasal bone during the first trimester strongly suggests Trisomy 21.
Normal Appearance of Nasal Bone:
Three lines visible in mid-sagittal view:
1️⃣ Skin line (Top Line)
2️⃣ Nasal bone (Middle Line – should be brighter than skin)
3️⃣ Tip of the nose (Lowest Line
Absent or underdeveloped nasal bone
Found in 60-70% of Trisomy 21 cases
Observed in Trisomy 18, 13, and skeletal dysplasia.
Helpful Hint: Always check the premaxillary triangle to confirm nasal bone presence!
Ductus Venosus (DV) Doppler: The "Unseen Clue" in Aneuploidy
  • Measures blood flow between the umbilical vein and fetal heart.
  • Key Discovery:
Reversed A-wave indicates a high risk for Trisomy 21 & CHD.
Correct Doppler Procedure
✅ Sample volume should be between 0.5–1 mm.
✅ Use mid-sagittal plane; insonation angle less than 30°.
✅ Position the gate at ductus venosus entry into IVC.
Common Mistakes:
❌ Utilizing a large Doppler gate that captures hepatic veins instead.
❌ Measuring from an oblique angle. 
Tricuspid Regurgitation (TR) Doppler: The "Heart's Voice" 💓
Assesses right heart performance & CHD risk.
Importance:
Holosystolic TR with velocity exceeding 60 cm/s indicates potential Trisomy 21 or CHD.
Likelihood ratio (LR) for CHD = 8.4!
Common Errors:
❌ Placing sample gate on mitral valve instead of tricuspid valve.
❌ Using a small sample volume (should be ≥3mm
Intracranial Translucency (IT): The Spina Bifida Indicator
Represents anechoic space of the fourth ventricle.
Obliteration or loss of IT suggests:
  1.  Open Spina Bifida
  2.  Neural tube defects
Helpful Tip: Watch for the "Crash Sign" (cerebral peduncles pressed against the occipital bone).
SECTION 3: FMF Certification & Practical Application
Step-by-Step Guide for First-Trimester Screening
️⃣ Measure NT (most critical marker).
2️⃣ Check Nasal Bone for hypoplasia or absence.
3️⃣ Conduct DV Doppler (look for reversed A-wave).
4️⃣ Evaluate TR Doppler (velocity over 60 cm/s is concerning!).
5️⃣ Assess IT for spina bifida risk.
When to Refer for Additional Testing?
  • High-risk screening → Recommend NIPT or CVS/Amniocentesis.
  • NT over 3.5mm, absent NB, reversed DV A-wave → Immediate referral needed.
  • First-trimester suspicion of CHD → Arrange fetal echocardiography at 18-22 weeks.
SECTION 4: Key Takeaways & Everyday Practice Tips
✔ NT over 95th percentile? Further investigation required!
✔ Absent nasal bone? Strong indicator of aneuploidy.
✔ Reversed A-wave in DV? Investigate potential Trisomy 21 or CHD.
✔ Tricuspid regurgitation? High probability of congenital heart defects.
✔ Obliteration of IT? Likely indicates open spina bifida
Helpful Hint: Always adhere to FMF guidelines to maintain high accuracy in first-trimester screening!

PART 5: Advanced First-Trimester Screening – Practical Cases and Learning Opportunities

Having grasped the essential markers, let’s explore actual scenarios and their applications to ensure you can effectively implement this knowledge in your practice.

CASE 1: Elevated NT with Normal Other Markers – What’s the Next Step?

Situation:

At 12 weeks of gestation, NT measures 3.8mm (Above the 99th percentile

Nasal bone is visible

Ductus Venosus Doppler shows a normal A-wave

Tricuspid Valve Doppler indicates no regurgitation

No structural abnormalities detected
Your Plan of Action:

Step 1: Evaluate Risk Based on NT Measurement 

 An NT greater than 3.5mm indicates a high risk for aneuploidy and congenital heart disease (CHD), but with other markers being normal, the risk is mitigated. 

 ✅ Step 2: Discuss Follow-Up Options with the Patient:

 NIPT (the most reliable non-invasive test) Early fetal echocardiography at 14-16 weeks (If NT remains elevated, assess for CHD). 

 ✅ Step 3: Keep a Close Watch on the Pregnancy 

 Even if fetal karyotype and anatomy scan are normal, the risk of CHD persists at 2-5% → A detailed fetal echocardiography is warranted between 18-22 weeks.

✔ Key Takeaway: An elevated NT does not necessarily indicate aneuploidy, but thorough follow-up is crucial for detecting potential heart defects.

📌 CASE 2: Missing Nasal Bone – Is It Trisomy 21 or a Normal Variation?

📝 Situation:

NT is 1.8mm (Normal range)

Nasal Bone absent at 12 weeks

Ductus Venosus Doppler shows a normal A-wave

Tricuspid Valve Doppler indicates no regurgitation

🚀 Your Plan of Action:

✅ Step 1: Re-evaluate the Image Quality

Ensure the mid-sagittal view is accurate and the transducer is aligned parallel to the nose (to avoid misinterpretation).

✅ Step 2: Consider Ethnic Background

In certain African and Asian populations, nasal bone ossification may develop later, possibly resulting in false positives.

✅ Step 3: Provide Additional Testing Options

If risk factors are present (such as maternal age or previous T-21 pregnancy) → Suggest NIPT.

If risk factors are low, schedule a follow-up scan at 14-16 weeks to reassess the nasal bone.

✔ Key Takeaway:

The absence of a nasal bone is a significant marker for Trisomy 21 but can vary by ethnicity → Always confirm with additional markers before drawing conclusions.

CASE 3: Reversed A-Wave in DV – Does This Indicate High Risk?

📝 Situation:

At 11+5 weeks, NT is measured at 2.1mm (Within normal limits)

Nasal bone is present

Ductus Venosus Doppler shows a reversed A-wave

Tricuspid Valve Doppler indicates normal function

🚀 Your Plan of Action:

✅ Step 1: Verify the Doppler Image Quality

Use a small sample gate (0.5-1mm) to prevent contamination from the hepatic vein.

✅ Step 2: Analyze Overall Risk

A reversed A-wave alone increases the risk for aneuploidy and CHD by 2-3 times, but other markers are normal.

✅ Step 3: Suggest Further Testing

First option: NIPT

If parents desire definitive results: CVS (Chorionic Villus Sampling).

✔ Key Takeaway:

A reversed A-wave in DV is a notable risk factor for aneuploidy and CHD but should be evaluated alongside other indicators.

📌 CASE 4: Severe TR + Thick NT – Are We Looking at CHD or Trisomy 21?

📝 Situation:

At 12+2 weeks, NT measures a thick 4.8mm

Nasal bone is visible

Ductus Venosus shows a reversed A-wave

Severe Tricuspid Regurgitation >80 cm/s

Four-chamber heart view reveals right atrial enlargement

🚀 Your Plan of Action:

✅ Step 1: Identify High-Risk Indicators

Severe TR combined with a reversed DV A-wave and thick NT strongly suggests CHD (such as AVSD or HLHS).

✅ Step 2: Refer for Early Echocardiography (14-16 Weeks)

Fetal heart defects may be found in 30-40% of these instances!

✅ Step 3: Explore Genetic Testing Options

High likelihood of Trisomy 21 (Down Syndrome)

Offer NIPT or CVS.

✔ Key Takeaway:

Severe TR is more indicative of congenital heart disease than aneuploidy alone.

Final Cheat Sheet for Clinical Decision Making:

Finding

Primary Concern

Next Step

Thick NT (>3.5mm)

Trisomy 21, CHD

NIPT or Fetal Echo

Absent Nasal Bone

Trisomy 21, 18

Reassess at 14-16 weeks

Reversed A-wave (DV)

Trisomy 21, CHD

Consider NIPT

Tricuspid Regurgitation >60 cm/s

CHD, Trisomy 21

Fetal Echocardiography

Intracranial Translucency Loss

Open Spina Bifida

Detailed Neurosonogram